Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999804705> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1999804705 endingPage "109" @default.
- W1999804705 startingPage "91" @default.
- W1999804705 abstract "At the beginning of the four chapters on phenomena, analysis, pathophysiology and therapy of cystinuria the essentials of the published literature are summarized. The frequency of cystinuria is in the order of 1:10,000. Besides the cystine lithiasis occurring in nine tenths of all cystinuria patients neurological diseases may also be observed. All commonly applied methods to analyze cystine detect the sum of cystine and cysteine. Cystinuria is characterized by a higher cystine excretion, up to the 100-fold of the normal. Also the concentrations of lysine, arginine and ornithine in the urine of cystinuria patients are elevated, caused by intestinal and renal transport defects. Inevitable damage of renal parenchyma by multiple operations can drastically be reduced by the therapy with D-penicillamine or alpha-mercaptopropionylglycine. The disadvantages of that formation of soluble asymmetric disulfides are the side effects, such as nausea, gastric difficulties and dermatosis, occurring in up to 50% of the patients. Using the especially developed method with HPLC separation and electrochemical detector with a mercury electrode, cystine and cysteine are analyzed simultaneously. In the urine of healthy persons the molar concentration of cysteine is in the same order as cystine. But in cystinuria the cysteine concentration in urine is about a thousand times less than that of cystine. These results are evidence that a shifted redox-equilibrium of cystine-cysteine is also typical of cystinuria. The molar cysteine percentage of cysteine in healthy persons is increased from 30 to 50% by oral ascorbic acid administration. Therefore a vitamin C therapy for cystinuria is developed. 31 cystinuria patients who receive 5 g of vitamin C a day show a decrease in the cystine concentration of about 40%. Up to now, no side effects have been observed. The most obvious sign of the positive effect of the proposed vitamin C therapy for cystinuria is the missing cystine sediment in fresh urine." @default.
- W1999804705 created "2016-06-24" @default.
- W1999804705 creator A5050514377 @default.
- W1999804705 creator A5057285180 @default.
- W1999804705 date "1982-01-01" @default.
- W1999804705 modified "2023-09-25" @default.
- W1999804705 title "Cystinurietherapie mit Ascorbinsäure" @default.
- W1999804705 doi "https://doi.org/10.1159/000280803" @default.
- W1999804705 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7112765" @default.
- W1999804705 hasPublicationYear "1982" @default.
- W1999804705 type Work @default.
- W1999804705 sameAs 1999804705 @default.
- W1999804705 citedByCount "18" @default.
- W1999804705 crossrefType "journal-article" @default.
- W1999804705 hasAuthorship W1999804705A5050514377 @default.
- W1999804705 hasAuthorship W1999804705A5057285180 @default.
- W1999804705 hasConcept C10146269 @default.
- W1999804705 hasConcept C126322002 @default.
- W1999804705 hasConcept C134018914 @default.
- W1999804705 hasConcept C181199279 @default.
- W1999804705 hasConcept C185592680 @default.
- W1999804705 hasConcept C2776608514 @default.
- W1999804705 hasConcept C2776796294 @default.
- W1999804705 hasConcept C2777468819 @default.
- W1999804705 hasConcept C2777608289 @default.
- W1999804705 hasConcept C2779201268 @default.
- W1999804705 hasConcept C2779950389 @default.
- W1999804705 hasConcept C2780026642 @default.
- W1999804705 hasConcept C2986274086 @default.
- W1999804705 hasConcept C31903555 @default.
- W1999804705 hasConcept C515207424 @default.
- W1999804705 hasConcept C55493867 @default.
- W1999804705 hasConcept C71924100 @default.
- W1999804705 hasConcept C98274493 @default.
- W1999804705 hasConceptScore W1999804705C10146269 @default.
- W1999804705 hasConceptScore W1999804705C126322002 @default.
- W1999804705 hasConceptScore W1999804705C134018914 @default.
- W1999804705 hasConceptScore W1999804705C181199279 @default.
- W1999804705 hasConceptScore W1999804705C185592680 @default.
- W1999804705 hasConceptScore W1999804705C2776608514 @default.
- W1999804705 hasConceptScore W1999804705C2776796294 @default.
- W1999804705 hasConceptScore W1999804705C2777468819 @default.
- W1999804705 hasConceptScore W1999804705C2777608289 @default.
- W1999804705 hasConceptScore W1999804705C2779201268 @default.
- W1999804705 hasConceptScore W1999804705C2779950389 @default.
- W1999804705 hasConceptScore W1999804705C2780026642 @default.
- W1999804705 hasConceptScore W1999804705C2986274086 @default.
- W1999804705 hasConceptScore W1999804705C31903555 @default.
- W1999804705 hasConceptScore W1999804705C515207424 @default.
- W1999804705 hasConceptScore W1999804705C55493867 @default.
- W1999804705 hasConceptScore W1999804705C71924100 @default.
- W1999804705 hasConceptScore W1999804705C98274493 @default.
- W1999804705 hasIssue "2" @default.
- W1999804705 hasLocation W19998047051 @default.
- W1999804705 hasLocation W19998047052 @default.
- W1999804705 hasOpenAccess W1999804705 @default.
- W1999804705 hasPrimaryLocation W19998047051 @default.
- W1999804705 hasRelatedWork W1170979098 @default.
- W1999804705 hasRelatedWork W1554555925 @default.
- W1999804705 hasRelatedWork W1999804705 @default.
- W1999804705 hasRelatedWork W2025002704 @default.
- W1999804705 hasRelatedWork W2086700763 @default.
- W1999804705 hasRelatedWork W2109599160 @default.
- W1999804705 hasRelatedWork W2113412463 @default.
- W1999804705 hasRelatedWork W2167684375 @default.
- W1999804705 hasRelatedWork W4234711632 @default.
- W1999804705 hasRelatedWork W4291944323 @default.
- W1999804705 hasVolume "37" @default.
- W1999804705 isParatext "false" @default.
- W1999804705 isRetracted "false" @default.
- W1999804705 magId "1999804705" @default.
- W1999804705 workType "article" @default.